A mitochondria targeting aggregation-induced emission phototheranostic agent for photodynamic synergistic therapy of triple-negative breast cancer.
In vivo animal studies demonstrate that the synergistic combination of TMP's PDT activity and CpG's immunotherapeutic effects significantly suppresses tumor growth, and represents a promising adjuvant chemotherapy strategy capable of boosting immune activation and therapeutic outcomes against drug-resistant tumors.